# Target Organ Damage and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects

> **NCT02022618** · — · COMPLETED · sponsor: **Fundacion para la Investigacion y Formacion en Ciencias de la Salud** · enrollment: 454 (actual)

## Conditions studied

- Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02022618
- **Lead sponsor:** Fundacion para la Investigacion y Formacion en Ciencias de la Salud
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 454 (ACTUAL)
- **Last updated:** 2016-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02022618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02022618, "Target Organ Damage and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02022618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*